Skip to main content
Top
Published in: Clinical Rheumatology 11/2020

01-11-2020 | Leg Ulcer | Clinical Image

Clinical image: chronic skin ulcers in a patient with rheumatoid arthritis on immunosuppressant therapy

Authors: Takaaki Kobayashi, Brian L. Swick, Christine Cho

Published in: Clinical Rheumatology | Issue 11/2020

Login to get access

Excerpt

A 50-year-old woman with a history of rheumatoid arthritis (RA) and interstitial lung disease (ILD) on prednisone, methotrexate, and hydroxychloroquine presented with a 3-month history of chronic left leg ulcers. Lesions were initially red patches that later blistered and ulcerated. She did not have any associated systemic symptoms. She had never received any biologic agents such as tumor necrosis factor inhibitors for RA and ILD. Empiric treatment with topical gentamicin and clobetasol did not resolve skin lesions. Physical examination demonstrated multiple ulcerated lesions with surrounding erythema in various stages of healing along the left leg (Fig. 1a). Basic metabolic panel, complete blood count, and inflammatory markers were within normal limits. Human immunodeficiency virus screen was negative. An interferon-gamma release assay was negative. Chest radiograph showed known increased interstitial lung markings due to ILD, which were stable without new infiltration. Punch biopsy of proximal lesion demonstrated numerous suppurative granulomas with long beaded acid-fast bacilli (AFB, × 1000 magnification) (Fig. 1b). AFB culture was negative, but 16s ribosomal RNA gene sequencing detected Mycobacterium haemophilum. She was treated with ciprofloxacin, clarithromycin, rifampin, and intravenous amikacin for 2 months followed by ciprofloxacin, clarithromycin, and rifampin for 4 months. Due to drug-drug interaction, hydroxychloroquine was held, but the rest of immunosuppressive therapy was continued. At the end of therapy, her lesions significantly improved (Fig. 1c).
Literature
1.
go back to reference Dawson DJ, Jennis F (1980) Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum. J Clin Microbiol 11(2):190–192CrossRef Dawson DJ, Jennis F (1980) Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum. J Clin Microbiol 11(2):190–192CrossRef
2.
go back to reference Saubolle MA, Kiehn TE, White MH, Rudinsky MF, Armstrong D (1996) Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 9(4):435–447CrossRef Saubolle MA, Kiehn TE, White MH, Rudinsky MF, Armstrong D (1996) Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 9(4):435–447CrossRef
3.
go back to reference Kelley CF, Armstrong WS, Eaton ME (2011) Disseminated Mycobacterium haemophilum infection. Lancet Infect Dis 11(7):571–578CrossRef Kelley CF, Armstrong WS, Eaton ME (2011) Disseminated Mycobacterium haemophilum infection. Lancet Infect Dis 11(7):571–578CrossRef
4.
go back to reference Lindeboom JA, Bruijnesteijn van Coppenraet LE, van Soolingen D, Prins JM, Kuijper EJ (2011) Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clin Microbiol Rev 24(4):701–717CrossRef Lindeboom JA, Bruijnesteijn van Coppenraet LE, van Soolingen D, Prins JM, Kuijper EJ (2011) Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clin Microbiol Rev 24(4):701–717CrossRef
5.
go back to reference Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn C, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367–416CrossRef Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn C, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367–416CrossRef
6.
go back to reference Nookeu P, Angkasekwinai N, Foongladda S, Phoompoung P (2019) Clinical characteristics and treatment outcomes for patients infected with Mycobacterium haemophilum. Emerg Infect Dis 25(9):1648–1652CrossRef Nookeu P, Angkasekwinai N, Foongladda S, Phoompoung P (2019) Clinical characteristics and treatment outcomes for patients infected with Mycobacterium haemophilum. Emerg Infect Dis 25(9):1648–1652CrossRef
Metadata
Title
Clinical image: chronic skin ulcers in a patient with rheumatoid arthritis on immunosuppressant therapy
Authors
Takaaki Kobayashi
Brian L. Swick
Christine Cho
Publication date
01-11-2020
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 11/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05251-9

Other articles of this Issue 11/2020

Clinical Rheumatology 11/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.